E3 PreliminaryModerate confidencePEM unclearCross-SectionalPeer-reviewedReviewed
Myalgic encephalomyelitis/chronic fatigue syndrome patients exhibit altered T cell metabolism and cytokine associations.
Mandarano, Alexandra H, Maya, Jessica, Giloteaux, Ludovic et al. · The Journal of clinical investigation · 2020 · DOI
Quick Summary
This study looked at how immune cells (T cells) work differently in people with ME/CFS compared to healthy people. Researchers found that T cells from ME/CFS patients use energy less efficiently—they have trouble both producing energy at rest and responding when activated. These metabolic problems in immune cells may help explain why ME/CFS patients experience severe fatigue and other symptoms.
Why It Matters
Understanding T cell metabolic dysfunction provides a potential biological mechanism for ME/CFS symptoms and could guide development of targeted therapeutic interventions. This work strengthens the scientific basis for recognizing ME/CFS as an immune-mediated disease with measurable cellular abnormalities, validating patient experiences of fatigue and post-exertional malaise.
Observed Findings
- CD8+ T cells from ME/CFS patients had reduced mitochondrial membrane potential compared to healthy controls.
- Both CD4+ and CD8+ T cells showed reduced glycolysis at rest in ME/CFS patients.
- CD8+ T cells from ME/CFS patients exhibited reduced glycolysis following activation.
- ME/CFS patients demonstrated different patterns of correlation between T cell metabolic measures and plasma cytokine levels compared to healthy controls.
Inferred Conclusions
- T cell metabolism is impaired in ME/CFS patients in ways consistent with ongoing immune dysfunction.
- The metabolic abnormalities may contribute to the mechanism underlying severe fatigue and post-exertional malaise.
- Disrupted relationships between cellular metabolism and circulating cytokines suggest systemic immune dysregulation in ME/CFS.
Remaining Questions
- Are the observed metabolic abnormalities primary drivers of ME/CFS symptoms or secondary consequences of disease pathology?
- Do these T cell metabolic changes persist over time or fluctuate with disease activity?
- Can correcting T cell metabolism reduce symptoms and improve patient outcomes?
What This Study Does Not Prove
This study identifies metabolic abnormalities but does not prove they cause ME/CFS symptoms or are specific to this disease. It cannot establish whether T cell dysfunction is a primary cause or a consequence of disease processes. The correlation between metabolism and cytokines does not establish causation, and findings require validation in larger, prospective studies.
Tags
Symptom:Post-Exertional MalaiseFatigue
Biomarker:CytokinesGene ExpressionBlood Biomarker
Phenotype:Infection-Triggered
Method Flag:PEM Not DefinedSmall SampleExploratory OnlyWeak Case Definition
Metadata
- DOI
- 10.1172/JCI132185
- PMID
- 31830003
- Review status
- Editor reviewed
- Evidence level
- Early hypothesis, preprint, editorial, or weak support
- Last updated
- 12 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.